Frontiers in Oncology | Cancer Immunity and Immunotherapy

Original Research

Published on 07 Dec 2023

Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Justin B. Hackett
Nicholas Ramos
Stephen Barr
Madeline Bross
Nerissa T. Viola
Heather M. Gibson

Frontiers in Oncology

doi 10.3389/fonc.2023.1285117

2,469 views
1 citation

Review

Published on 06 Dec 2023

Immunogenic chemotherapy: great potential for improving response rates

in Cancer Immunity and Immunotherapy

Xiaojun Huang
Qinghuan Ren
Leixiang Yang
Di Cui
Chenyang Ma
Yueliang Zheng
Junjie Wu

Frontiers in Oncology

doi 10.3389/fonc.2023.1308681

2,281 views
9 citations

Review

Published on 05 Dec 2023

Role of gonadally synthesized steroid hormones in the colorectal cancer microenvironment

in Cancer Immunity and Immunotherapy

Liu Wenxuan
Li Liu
Lilong Zhang
Zhendong Qiu
Zhongkai Wu
Wenhong Deng

Frontiers in Oncology

doi 10.3389/fonc.2023.1323826

1,579 views
6 citations

Mini Review

Published on 04 Dec 2023

Circadian lifestyle determinants of immune checkpoint inhibitor efficacy

in Cancer Immunity and Immunotherapy

Bethan R. Hughes
Sadiq Shanaz
Seline Ismail-Sutton
Nicholas I. Wreglesworth
Christian P. Subbe
Pasquale F. Innominato

Frontiers in Oncology

doi 10.3389/fonc.2023.1284089

3,158 views
1 citation

Mini Review

Published on 01 Dec 2023

A narrative review of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Robert Hsu
David J. Benjamin

Frontiers in Oncology

doi 10.3389/fonc.2023.1252652

13,418 views
4 citations

Review

Published on 28 Nov 2023

The multiple roles of C-type lectin receptors in cancer

in Cancer Immunity and Immunotherapy

Qiao Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1301473

2,541 views
5 citations

Review

Published on 28 Nov 2023

Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC

in Cancer Immunity and Immunotherapy

Wanting Shi
Kang Li
Yonghong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1185142

3,515 views

Original Research

Published on 28 Nov 2023

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

in Cancer Immunity and Immunotherapy

Furong Kou
Jian Li
Yanshuo Cao
Zhi Peng
Ting Xu
Lin Shen
Jifang Gong
Xicheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1285478

1,487 views
2 citations

Case Report

Published on 28 Nov 2023

A case report and literature review on reactive cutaneous capillary endothelial proliferation induced by camrelizumab in a nasopharyngeal carcinoma patient

in Cancer Immunity and Immunotherapy

Yao Lin
Yuxin Lin
Xiaoping Zhong
Qingshan Chen
Shijie Tang
Jiasheng Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1280208

1,364 views
2 citations

Review

Published on 22 Nov 2023

Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy

in Cancer Immunity and Immunotherapy

Huaiyuan Zhang
Ziyuan Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1257515

3,588 views
8 citations

Mini Review

Published on 22 Nov 2023

Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?

in Cancer Immunity and Immunotherapy

Arailym Sarsembayeva
Rudolf Schicho

Frontiers in Oncology

doi 10.3389/fonc.2023.1296906

5,143 views
6 citations

Original Research

Published on 22 Nov 2023

Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Jonathan Khalifa
Noémie Thébault
Clara-Maria Scarlata
Emma Norkowski
Carole Massabeau
Laurent Brouchet
Sophie Peries Bataille
Christelle Casaroli
Liza Vaz
Carine Valle

Frontiers in Oncology

doi 10.3389/fonc.2023.1269166

2,254 views

Original Research

Published on 20 Nov 2023

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model

in Cancer Immunity and Immunotherapy

Mariangela Garofalo
Magdalena Wieczorek
Ines Anders
Monika Staniszewska
Michal Lazniewski
Marta Prygiel
Aleksandra Anna Zasada
Teresa Szczepińska
Dariusz Plewczynski
Stefano Salmaso

Frontiers in Oncology

doi 10.3389/fonc.2023.1259314

3,513 views
4 citations

Review

Published on 16 Nov 2023

Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections

in Cancer Immunity and Immunotherapy

Diego Esperante
Mónica Itzel Martínez Gutiérrez
Mark E. Issa
Alejandro Schcolnik-Cabrera
Fela Mendlovic

Frontiers in Oncology

doi 10.3389/fonc.2023.1251355

2,269 views

Review

Published on 15 Nov 2023

The power of phages: revolutionizing cancer treatment

in Cancer Immunity and Immunotherapy

Md. Sharifull Islam
Jie Fan
Fan Pan

Frontiers in Oncology

doi 10.3389/fonc.2023.1290296

10,969 views
13 citations

Review

Published on 09 Nov 2023

Triple-negative breast cancer: from none to multiple therapeutic targets in two decades

in Cancer Immunity and Immunotherapy

Filomena Marino Carvalho

Frontiers in Oncology

doi 10.3389/fonc.2023.1244781

4,507 views
10 citations

Navigation group

Articles

Interferon gamma immunoPET imaging to evaluate response to immune checkpoint inhibitors

Immunogenic chemotherapy: great potential for improving response rates

Role of gonadally synthesized steroid hormones in the colorectal cancer microenvironment

Circadian lifestyle determinants of immune checkpoint inhibitor efficacy

A narrative review of antibody–drug conjugates in EGFR-mutated non-small cell lung cancer

The multiple roles of C-type lectin receptors in cancer

Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC

Immune checkpoint inhibitor-induced colitis with endoscopic evaluation in Chinese cancer patients: a single-centre retrospective study

A case report and literature review on reactive cutaneous capillary endothelial proliferation induced by camrelizumab in a nasopharyngeal carcinoma patient

Gut–lung axis: role of the gut microbiota in non-small cell lung cancer immunotherapy

Cannabinoids and the endocannabinoid system in immunotherapy: helpful or harmful?

Immune changes in hilar tumor draining lymph nodes following node sparing neoadjuvant chemoradiotherapy of localized cN0 non-small cell lung cancer

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model

Similarities and divergences in the metabolism of immune cells in cancer and helminthic infections

The power of phages: revolutionizing cancer treatment

Triple-negative breast cancer: from none to multiple therapeutic targets in two decades